FDA Moves to Accelerate Biosimilar Development and Lower Drug Costs
October 29, 2025
October 29, 2025
WASHINGTON, Oct. 29 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following news release:
* * *
FDA Moves to Accelerate Biosimilar Development and Lower Drug Costs
*
The U.S. Food and Drug Administration (FDA) today announced significant action to make it faster and less costly to develop biosimilar medicines, which are lower-cost "generic" alternatives to biologic drugs that treat serious . . .
* * *
FDA Moves to Accelerate Biosimilar Development and Lower Drug Costs
*
The U.S. Food and Drug Administration (FDA) today announced significant action to make it faster and less costly to develop biosimilar medicines, which are lower-cost "generic" alternatives to biologic drugs that treat serious . . .